Loading…
Simultaneous vitality and DNA‐fragmentation measurement in spermatozoa of smokers and non‐smokers
Background Because cigarette smoke is a powerful ROS producer, we hypothesized that the spermatozoa of smokers would be more at risk of having increased DNA fragmentation than spermatozoa of non‐smoking men. Methods A cross‐sectional study was performed on consenting smokers and non‐smokers, consult...
Saved in:
Published in: | Cytometry. Part B, Clinical cytometry Clinical cytometry, 2015-03, Vol.88 (2), p.120-124 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Because cigarette smoke is a powerful ROS producer, we hypothesized that the spermatozoa of smokers would be more at risk of having increased DNA fragmentation than spermatozoa of non‐smoking men.
Methods
A cross‐sectional study was performed on consenting smokers and non‐smokers, consulting in an infertility clinic for routine sperm analysis. The application of a novel TUNEL assay coupled to a vitality marker, LIVE/DEAD®, allowed both DNA fragmentation and viability measurement within spermatozoa of participants to be analyzed by flow cytometry.
Results
The coupled vitality‐DNA fragmentation analysis revealed that non‐smokers and smokers, respectively presented medians of 3.6% [0.6–36.8] and 3.3% [0.9–9.6] DNA fragmented spermatozoa among the living spermatozoa population (P > 0.05).
Conclusion
No deleterious effect of smoking on spermatozoa was found in our study. More studies concerning potential mutagenic capacities of cigarette smoke on spermatozoa are necessary. In addition, the coupled vitality‐DNA fragmentation analysis may orient Assisted Reproductive Technology teams when confronted with patients having a high percentage of DNA‐fragmented living spermatozoa. © 2014 International Clinical Cytometry Society |
---|---|
ISSN: | 1552-4949 1552-4957 |
DOI: | 10.1002/cyto.b.21185 |